PL3030272T3 - Sposób traktowania enzymatycznego produktów tkankowych - Google Patents

Sposób traktowania enzymatycznego produktów tkankowych

Info

Publication number
PL3030272T3
PL3030272T3 PL14776766T PL14776766T PL3030272T3 PL 3030272 T3 PL3030272 T3 PL 3030272T3 PL 14776766 T PL14776766 T PL 14776766T PL 14776766 T PL14776766 T PL 14776766T PL 3030272 T3 PL3030272 T3 PL 3030272T3
Authority
PL
Poland
Prior art keywords
enzymatic treatment
tissue products
tissue
products
enzymatic
Prior art date
Application number
PL14776766T
Other languages
English (en)
Inventor
Yi Chen
Nimesh KABARIA
Kai-Roy Wang
Hui Xu
Patrick Leamy
Hua Wan
Wenquan Sun
Li Ting Huang
Original Assignee
Lifecell Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/019,274 external-priority patent/US9238793B2/en
Application filed by Lifecell Corporation filed Critical Lifecell Corporation
Publication of PL3030272T3 publication Critical patent/PL3030272T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/58—Adhesives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3633—Extracellular matrix [ECM]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3695—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the function or physical properties of the final product, where no specific conditions are defined to achieve this

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Botany (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Materials For Medical Uses (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
PL14776766T 2013-09-05 2014-09-05 Sposób traktowania enzymatycznego produktów tkankowych PL3030272T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14/019,274 US9238793B2 (en) 2011-04-28 2013-09-05 Method for enzymatic treatment of tissue products
EP14776766.9A EP3030272B1 (en) 2013-09-05 2014-09-05 Method for enzymatic treatment of tissue products
PCT/US2014/054206 WO2015035115A1 (en) 2013-09-05 2014-09-05 Method for enzymatic treatment of tissue products

Publications (1)

Publication Number Publication Date
PL3030272T3 true PL3030272T3 (pl) 2019-12-31

Family

ID=51626141

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14776766T PL3030272T3 (pl) 2013-09-05 2014-09-05 Sposób traktowania enzymatycznego produktów tkankowych

Country Status (14)

Country Link
EP (3) EP3030272B1 (pl)
JP (2) JP6524560B2 (pl)
KR (3) KR102263617B1 (pl)
CN (2) CN115154668A (pl)
AU (3) AU2014315111B2 (pl)
CA (1) CA2919257C (pl)
DK (1) DK3030272T3 (pl)
ES (1) ES2743441T3 (pl)
HU (1) HUE045484T2 (pl)
IL (1) IL243674B (pl)
PL (1) PL3030272T3 (pl)
RU (1) RU2681530C2 (pl)
SG (2) SG11201600353QA (pl)
WO (1) WO2015035115A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11052175B2 (en) 2015-08-19 2021-07-06 Musculoskeletal Transplant Foundation Cartilage-derived implants and methods of making and using same
CA3025501A1 (en) 2016-06-03 2017-12-07 Lifecell Corporation Methods for localized modification of tissue products
CN114377206B (zh) * 2021-12-24 2022-09-30 杭州华迈医疗科技有限公司 一种脱细胞基质生物材料的制备方法
CN114276974A (zh) * 2021-12-24 2022-04-05 上海理工大学 封装细胞的间质材料及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6166288A (en) 1995-09-27 2000-12-26 Nextran Inc. Method of producing transgenic animals for xenotransplantation expressing both an enzyme masking or reducing the level of the gal epitope and a complement inhibitor
US6758865B1 (en) * 1998-03-06 2004-07-06 Crosscart, Inc. Soft tissue xenografts
US6383732B1 (en) * 1999-02-11 2002-05-07 Crosscart, Inc. Method of preparing xenograft heart valves
AUPS242702A0 (en) * 2002-05-21 2002-06-13 Colltech Australia Limited Improved method for the extraction and purification of collagen
US20040191226A1 (en) * 2002-12-04 2004-09-30 Badylak Stephen F. Method for repair of body wall
US20050186286A1 (en) * 2004-02-25 2005-08-25 Yoshihiro Takami Skin decellularization method, acellular dermal matrix and production method therefore employing said decellularization method, and composite cultured skin employing said matrix
GB0807868D0 (en) * 2008-04-30 2008-06-04 Knight David P Cartilage repair material and a method for the preparation thereof
KR101234328B1 (ko) 2009-07-27 2013-02-18 라이프 퓨젼 엘엘씨 고순도 콜라겐의 제조 방법
US8198408B2 (en) * 2009-07-27 2012-06-12 National Cheng Kung University Method for preparing porous collagen matrices
BR112013027307B1 (pt) * 2011-04-28 2020-02-04 Lifecell Corp método para tratar uma matriz de tecido
US20130122583A1 (en) * 2011-11-10 2013-05-16 Celxcel Pty Ltd Sterilization process

Also Published As

Publication number Publication date
HUE045484T2 (hu) 2019-12-30
EP4052735A1 (en) 2022-09-07
CA2919257A1 (en) 2015-03-12
AU2014315111B2 (en) 2017-09-07
RU2016104899A3 (pl) 2018-07-09
JP6524560B2 (ja) 2019-06-05
SG11201600353QA (en) 2016-03-30
RU2016104899A (ru) 2017-10-10
EP3030272A1 (en) 2016-06-15
KR20160053972A (ko) 2016-05-13
AU2020200601A1 (en) 2020-02-20
KR102263617B1 (ko) 2021-06-10
SG10202004124UA (en) 2020-06-29
WO2015035115A1 (en) 2015-03-12
KR20200019265A (ko) 2020-02-21
KR20210008145A (ko) 2021-01-20
KR102080371B1 (ko) 2020-02-21
AU2014315111A1 (en) 2016-02-11
AU2017272156A1 (en) 2017-12-21
IL243674A0 (en) 2016-02-29
DK3030272T3 (da) 2019-09-09
KR102203782B1 (ko) 2021-01-18
CN115154668A (zh) 2022-10-11
CN105492034A (zh) 2016-04-13
JP2016530025A (ja) 2016-09-29
AU2017272156B2 (en) 2019-12-05
EP3549616A1 (en) 2019-10-09
IL243674B (en) 2021-06-30
JP6816202B2 (ja) 2021-01-20
JP2019162440A (ja) 2019-09-26
CA2919257C (en) 2022-05-10
ES2743441T3 (es) 2020-02-19
EP3030272B1 (en) 2019-05-29
RU2681530C2 (ru) 2019-03-07
EP3549616B1 (en) 2022-04-27

Similar Documents

Publication Publication Date Title
IL272509A (en) A method for enzymatic treatment of tissue products
ZA201700183B (en) Acetylcholinesterase inhibitors for treatment of dermatological conditions
EP3084000A4 (en) Method of diagnosis and treatment
PT2978890T (pt) Novo método para coloração e tratamento de substratos
EP3038663A4 (en) Method of performing sterilization cycle
HK1216504A1 (zh) 疾病的治療方法
IL243674B (en) A method for enzymatic treatment of tissue products
IL241096B (en) Treatment methods
GB201308466D0 (en) Improved process for treatment of minewater
EP2994461A4 (en) Methods of treating skin conditions using cyclolignan compounds
AU2013904712A0 (en) Method of Treatment
GB201322778D0 (en) Method of treatment
AU2013904170A0 (en) Method of treatment
GB201314882D0 (en) Method of treatment
GB201221032D0 (en) Method of treatment
GB201207894D0 (en) Method of treatment
AU2013902513A0 (en) Method of treatment or prophylaxis
AU2013904912A0 (en) Method of Diagnosis and Treatment
AU2012905240A0 (en) Method of Treatment
AU2012904724A0 (en) Method of treatment
EP2911662A4 (en) METHOD OF TREATING A DISEASE
AU2013901359A0 (en) Methods of Treatment